{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T03:50:40Z","timestamp":1789876240118,"version":"4.0.1"},"reference-count":30,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,8,13]],"date-time":"2020-08-13T00:00:00Z","timestamp":1597276800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100005192","name":"California HIV\/AIDS Research Program","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005192","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","japha.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Pharmacists Association"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.japh.2020.06.005","type":"journal-article","created":{"date-parts":[[2020,7,12]],"date-time":"2020-07-12T00:00:47Z","timestamp":1594512047000},"page":"e179-e183","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Attitudes about community pharmacy access to HIV prevention medications in California"],"prefix":"10.1016","volume":"60","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0023-1127","authenticated-orcid":false,"given":"Kimberly A.","family":"Koester","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parya","family":"Saberi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6070-8172","authenticated-orcid":false,"given":"Shannon M.","family":"Fuller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3968-9100","authenticated-orcid":false,"given":"Emily A.","family":"Arnold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9692-1968","authenticated-orcid":false,"given":"Wayne T.","family":"Steward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"27","key":"10.1016\/j.japh.2020.06.005_bib1","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1056\/NEJMoa1011205","article-title":"Preexposure chemoprophylaxis for HIV prevention in men who have sex with men","volume":"363","author":"Grant","year":"2010","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.japh.2020.06.005_bib2","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1521\/aeap.2017.29.4.315","article-title":"Barriers to access and adoption of pre-exposure prophylaxis for the prevention of HIV among men who have sex with men (MSM) in a relatively rural state","volume":"29","author":"Hubach","year":"2017","journal-title":"AIDS Educ Prev"},{"issue":"11","key":"10.1016\/j.japh.2020.06.005_bib3","doi-asserted-by":"crossref","first-page":"3576","DOI":"10.1007\/s10461-018-2067-8","article-title":"Facilitators and barriers to pre-exposure prophylaxis (PrEP) use among black individuals in the United States: results from the National Survey on HIV in the Black Community (NSHBC)","volume":"22","author":"Ojikutu","year":"2018","journal-title":"AIDS Behav"},{"issue":"8","key":"10.1016\/j.japh.2020.06.005_bib4","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1089\/apc.2014.0303","article-title":"Minimal awareness and stalled uptake of pre-exposure prophylaxis (PrEP) among at risk, HIV-negative, Black men who have sex with men","volume":"29","author":"Eaton","year":"2015","journal-title":"AIDS Patient Care STDS"},{"issue":"14","key":"10.1016\/j.japh.2020.06.005_bib5","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1177\/0956462415570159","article-title":"Perceptions of and intentions to adopt HIV pre-exposure prophylaxis among black men who have sex with men in Los Angeles","volume":"26","author":"Brooks","year":"2015","journal-title":"Int J STD AIDS"},{"issue":"41","key":"10.1016\/j.japh.2020.06.005_bib6","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.15585\/mmwr.mm6741a3","article-title":"HIV preexposure prophylaxis, by race and ethnicity - United States, 2014-2016","volume":"67","author":"Huang","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.japh.2020.06.005_bib7","author":"Sullivan"},{"issue":"9","key":"10.1016\/j.japh.2020.06.005_bib8","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1001\/jama.2019.1343","article-title":"Ending the\u00a0HIV epidemic: a plan for the United States","volume":"321","author":"Fauci","year":"2019","journal-title":"JAMA"},{"issue":"7","key":"10.1016\/j.japh.2020.06.005_bib9","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1007\/s10461-018-02383-7","article-title":"Predicting pharmacist dispensing practices and comfort related to pre-exposure prophylaxis for HIV prevention (PrEP)","volume":"23","author":"Meyerson","year":"2019","journal-title":"AIDS Behav"},{"issue":"14","key":"10.1016\/j.japh.2020.06.005_bib10","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1186\/1472-6963-14-261","article-title":"Pharmacies as providers of expanded health services for people who inject drugs: a review of laws, policies, and barriers in six countries","author":"Hammett","year":"2014","journal-title":"BMC Health Serv Res"},{"issue":"2","key":"10.1016\/j.japh.2020.06.005_bib11","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1331\/154434506776180621","article-title":"Pharmacist involvement with immunizations: a decade of professional advancement [published correction appears in J Am Pharm Assoc (Wash DC). 2006;46(3):308]","volume":"46","author":"Hogue","year":"2006","journal-title":"J\u00a0Am Pharm Assoc (2003)"},{"issue":"2","key":"10.1016\/j.japh.2020.06.005_bib12","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1331\/JAPhA.2008.07138","article-title":"Pharmacist prescribing of hormonal contraceptives: results of the direct access study","volume":"48","author":"Gardner","year":"2008","journal-title":"J\u00a0Am Pharm Assoc (2003)"},{"issue":"7","key":"10.1016\/j.japh.2020.06.005_bib13","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1592\/phco.27.7.1040","article-title":"Tobacco interventions delivered by pharmacists: a summary and systematic review","volume":"27","author":"Dent","year":"2007","journal-title":"Pharmacotherapy"},{"issue":"31","key":"10.1016\/j.japh.2020.06.005_bib14","doi-asserted-by":"crossref","first-page":"679","DOI":"10.15585\/mmwr.mm6831e1","article-title":"Vital signs: pharmacy-based naloxone dispensing - United States, 2012-2018","volume":"68","author":"Guy","year":"2019","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"1","key":"10.1016\/j.japh.2020.06.005_bib15","first-page":"176","article-title":"Individual- and neighborhood-level characteristics associated with support of in-pharmacy vaccination among ESAP-registered pharmacies: pharmacists' role in reducing racial\/ethnic disparities in influenza vaccinations in New York City","volume":"88","author":"Crawford","year":"2011","journal-title":"J\u00a0Urban Health"},{"key":"10.1016\/j.japh.2020.06.005_bib16","first-page":"E149","article-title":"Provision of clinical preventive services by community pharmacists [published correction appears in Prev Chronic Dis. 2016;13:E161]","volume":"13","author":"Kelling","year":"2016","journal-title":"Prev Chronic Dis"},{"issue":"19","key":"10.1016\/j.japh.2020.06.005_bib17","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.2146\/ajhp100077","article-title":"Economic effects of pharmacists on health outcomes in the United States: a systematic review","volume":"67","author":"Chisholm-Burns","year":"2010","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.japh.2020.06.005_bib18","author":"Tung"},{"issue":"6","key":"10.1016\/j.japh.2020.06.005_bib19","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1071\/SH18084","article-title":"Implementation of a community pharmacy-based PrEP service: a novel model for pre-exposure prophylaxis care","volume":"15","author":"Tung","year":"2018","journal-title":"Sex Health"},{"issue":"1","key":"10.1016\/j.japh.2020.06.005_bib20","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.japh.2019.06.021","article-title":"Implementation of pre-exposure prophylaxis at a community pharmacy through a collaborative practice agreement with San Francisco Department of Public Health","volume":"60","author":"Lopez","year":"2020","journal-title":"J\u00a0Am Pharm Assoc (2003)"},{"issue":"5","key":"10.1016\/j.japh.2020.06.005_bib21","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1089\/apc.2018.0294","article-title":"The pharmacist\u2019s expanding role in HIV pre-exposure prophylaxis","volume":"33","author":"Farmer","year":"2019","journal-title":"AIDS Patient Care STDs"},{"issue":"2","key":"10.1016\/j.japh.2020.06.005_bib22","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/QAI.0000000000001579","article-title":"Evolving models and ongoing challenges for HIV preexposure prophylaxis implementation in the United States","volume":"77","author":"Mayer","year":"2018","journal-title":"J\u00a0Acquir Immune Defic Syndr"},{"issue":"1","key":"10.1016\/j.japh.2020.06.005_bib23","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1331\/JAPhA.2015.14069","article-title":"Consumer interest in community pharmacy HIV screening services","volume":"55","author":"Darin","year":"2015","journal-title":"J\u00a0Am Pharm Assoc (2003)"},{"issue":"1","key":"10.1016\/j.japh.2020.06.005_bib24","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1331\/JAPhA.2015.14070","article-title":"Pharmacist-provided rapid HIV testing in two community pharmacies","volume":"55","author":"Darin","year":"2015","journal-title":"J\u00a0Am Pharm Assoc (2003)"},{"issue":"5","key":"10.1016\/j.japh.2020.06.005_bib25","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1331\/JAPhA.2014.14045","article-title":"HIV testing in community pharmacies and retail clinics: a model to expand access to screening for HIV infection","volume":"54","author":"Weidle","year":"2014","journal-title":"J\u00a0Am Pharm Assoc (2003)"},{"key":"10.1016\/j.japh.2020.06.005_bib26","series-title":"The Art of Case Study Research","author":"Stake","year":"1995"},{"key":"10.1016\/j.japh.2020.06.005_bib27","series-title":"Qualitative Data Analysis: An Expanded Sourcebook","author":"Miles","year":"1994"},{"key":"10.1016\/j.japh.2020.06.005_bib28","series-title":"The Grounded Theory Perspective: Conceptualization Contrasted with Description","author":"Glaser","year":"2001"},{"issue":"13","key":"10.1016\/j.japh.2020.06.005_bib29","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1177\/1049732316654870","article-title":"Member checking: a tool to enhance trustworthiness or merely a nod to validation?","volume":"26","author":"Birt","year":"2016","journal-title":"Qual Health Res"},{"issue":"26","key":"10.1016\/j.japh.2020.06.005_bib30","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1056\/NEJMp1912293","article-title":"PrEParing to end the HIV epidemic - California\u2019s route as a road map for the United States","volume":"381","author":"Kazi","year":"2019","journal-title":"N\u00a0Engl J Med"}],"container-title":["Journal of the American Pharmacists Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1544319120302715?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1544319120302715?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T05:47:39Z","timestamp":1761544059000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1544319120302715"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["S1544319120302715"],"URL":"https:\/\/doi.org\/10.1016\/j.japh.2020.06.005","relation":{},"ISSN":["1544-3191"],"issn-type":[{"value":"1544-3191","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Attitudes about community pharmacy access to HIV prevention medications in California","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Pharmacists Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.japh.2020.06.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 American Pharmacists Association\u00ae. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}